Mycophenolic acid plasma concentrations: influence of comedication.
about
Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part IAltered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitisPharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.Individualization of mycophenolate mofetil dose in renal transplant recipients.Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failureEvaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant PatientsImpact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?Enteric-coated mycophenolate sodium - current and future use in transplant patients.Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacMycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection.Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients.Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based Approach.Population Pharmacokinetics of Mycophenolic Acid: An Update.Individualizing immunosuppression in lung transplantation.
P2860
Q34125053-BE3AC5DB-2C0C-4B38-A634-78835FFFD398Q34610933-84710DF4-450E-41A6-9C1C-C5D9816AE681Q35842935-E6F00627-4EF7-492B-BB34-6A2A7A29918AQ36379888-87C24AE3-AFB4-4497-AB7B-0D98A4D3A8BEQ36407345-132FDADD-296A-44F1-81BE-CC28886B29E7Q36544988-3ADCD9CA-525B-4F91-9DDF-BA8DDAD3BC1AQ36736632-2B8195C0-1E41-42A7-A7AE-C87F1550CC73Q37201939-4E1ABFE4-ADAA-4D70-B8A8-C6DCAFF6D9A2Q37268535-2BD505DF-F2C0-46CB-A3E2-A32C23353A55Q37438051-DFE0C18A-BA8A-4D11-8950-FFEEAB21EEB7Q38223136-A01A6F01-8825-431A-9AC8-CC60A1927EE1Q40409829-39920186-5E58-475A-8DE0-BD92BC6CDD0FQ42597049-C0C0393F-688F-486B-8871-48339AA2E665Q43957906-331C5CA2-614A-4AB9-A4C3-CB010A28BD59Q43993075-DCBB70C0-837E-4C1E-8F39-4483422D15CEQ46208453-FB137859-06BA-4C66-80AF-AAAADEA01FCBQ46427135-AC388B43-D4D8-48B7-BA1C-D3FAB4223B9BQ46721818-52B8E9BE-5E1A-44B2-892A-7F500E87BDAFQ46942520-C1B8029F-C73D-44AE-B922-F729D3A71178Q47380142-EBA2DE38-F825-414E-8146-5086BB02B970Q47871343-674C0E5D-C7EA-4BD6-B90A-C54B67F60D20Q55385759-7EDE1360-4516-466C-8457-3166C88C6915
P2860
Mycophenolic acid plasma concentrations: influence of comedication.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mycophenolic acid plasma concentrations: influence of comedication.
@ast
Mycophenolic acid plasma concentrations: influence of comedication.
@en
type
label
Mycophenolic acid plasma concentrations: influence of comedication.
@ast
Mycophenolic acid plasma concentrations: influence of comedication.
@en
prefLabel
Mycophenolic acid plasma concentrations: influence of comedication.
@ast
Mycophenolic acid plasma concentrations: influence of comedication.
@en
P2093
P1476
Mycophenolic acid plasma concentrations: influence of comedication.
@en
P2093
Cantarell C
Capdevila L
Martorell J
Monforte V
Oppenheimer F
Vilardell J
P356
10.1097/00007691-200102000-00007
P577
2001-02-01T00:00:00Z